Table 5.
Group | Males | Females | ||
---|---|---|---|---|
Control | Treatment | Control | Treatment | |
AST (U/L) | 148.80 ± 5.99 | 149.56 ± 16.03 | 91.27 ± 8.75 | 93.25 ± 10.67 |
ALT (U/L) | 72.77 ± 8.88 | 72.59 ± 4.24 | 52.53 ± 7.36 | 54.41 ± 6.52 |
ALP (U/L) | 159.33 ± 9.29 | 163.24 ± 10.81 | 88.33 ± 8.50 | 89.72 ± 9.73 |
TBIL (μmol/L) | 1.00 ± 0.36 | 0.96 ± 0.21 | 1.03 ± 0.21 | 1.00 ± 0.25 |
TP (g/L) | 53.33 ± 3.68 | 53.64 ± 5.16 | 67.77 ± 4.50 | 68.47 ± 5.16 |
ALB (g/L) | 42.13 ± 3.44 | 39.55 ± 3.79 | 42.93 ± 2.60 | 44.61 ± 4.27 |
GLU (mmol/L) | 5.86 ± 1.60 | 5.97 ± 0.91 | 8.97 ± 0.87 | 8.62 ± 0.89 |
TG (mmol/L) | 0.48 ± 0.05 | 0.49 ± 0.10 | 0.51 ± 0.02 | 0.53 ± 0.05 |
TC (mmol/L) | 1.42 ± 0.11 | 1.45 ± 0.22 | 2.23 ± 0.25 | 2.19 ± 0.36 |
HDL (mmol/L) | 1.68 ± 0.25 | 1.65 ± 0.14 | 1.77 ± 0.31 | 1.83 ± 0.26 |
LDL (mmol/L) | 0.21 ± 0.09 | 0.20 ± 0.08 | 0.33 ± 0.08 | 0.32 ± 0.07 |
UREA (mmol/L) | 6.47 ± 1.32 | 6.81 ± 0.72 | 6.63 ± 0.38 | 6.54 ± 0.32 |
CRE (μmol/L) | 52.70 ± 4.93 | 54.62 ± 5.47 | 73.17 ± 2.35 | 71.28 ± 2.84 |
Na (mmol/L) | 140.93 ± 2.35 | 143.06 ± 2.61 | 142.17 ± 3.25 | 143.36 ± 4.29 |
Cl (mmol/L) | 105.40 ± 2.33 | 102.35 ± 2.68 | 100.67 ± 2.37 | 99.21 ± 3.11 |
Ca (mmol/L) | 2.69 ± 0.13 | 2.45 ± 0.35 | 2.56 ± 0.07 | 2.51 ± 0.08 |
P (mmol/L) | 3.12 ± 0.30 | 2.96 ± 0.27 | 2.48 ± 0.07 | 2.62 ± 0.05 |
Values are presented as mean ± standard deviation (n = 6).
Control, sterile normal saline; Treatment, 1 × 109 CFU of E. durans KLDS6.0930 /kg BW; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; TBIL, total bilirubin, TP, total protein; ALB, albumin; GLU, glucose; TG, triglycerides; TC, total cholesterol; HDL, high density lipoprotein cholesterol; LDL, low density lipoprotein cholesterol; UREA, urea; CRE, creatinine; Na, sodium; Cl, chloride; Ca, calcium; P, inorganic phosphorus.